SS Innovations International (SSII) Exchange Rate Effect (2022 - 2026)
SS Innovations International (SSII) reported Exchange Rate Effect of -$1.4 million for Q1 2026, down 5573.45% on a YoY basis from $25412.0 in Q1 2025, and down 141.78% sequentially from -$575291.0 in Q4 2025.
SS Innovations International (SSII) Exchange Rate Effect (2022 - 2026) Analysis & Trends
SS Innovations International (SSII) has 5 years of Exchange Rate Effect data on file, last reported at -$1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 5573.45% year-over-year to -$1.4 million; the trailing twelve-month figure through Mar 2026 stood at -$2.4 million (down 825.52% YoY), and the FY2025 full-year result was -$985026.0, down 459.21% from the prior year.
- Exchange Rate Effect fell to -$1.4 million in Q1 2026, from -$575291.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $447142.0 in Q4 2024 to a low of -$1.4 million in Q1 2026.
- A 5-year average of -$146559.3 and a median of -$31351.0 in 2024 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect jumped 342.41% in 2024 and slumped 5573.45% in 2026, its largest moves.
- Tracing SSII's Exchange Rate Effect over 5 years: stood at $103259.0 in 2022, then plunged by 278.64% to -$184459.0 in 2023, then jumped by 342.41% to $447142.0 in 2024, then plunged by 228.66% to -$575291.0 in 2025, then slumped by 141.78% to -$1.4 million in 2026.
- Business Quant data shows SSII's Exchange Rate Effect at -$1.4 million in Q1 2026, -$575291.0 in Q4 2025, and -$433112.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -23.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -19.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 33.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 8.20 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -2.80 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -37.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 45.66 Mn |
| 10 | SS Innovations International | 776.19 Mn | 752.58 Mn | 5.33 Mn | -1.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.39 Mn |
| Mar 31, 2026 | -1.39 Mn |
| Dec 31, 2025 | -575,291.00 |
| Dec 31, 2025 | -575,291.00 |
| Sep 30, 2025 | -433,112.00 |
| Sep 30, 2025 | -433,112.00 |
| Jun 30, 2025 | -2,035.00 |
| Jun 30, 2025 | -2,035.00 |
| Mar 31, 2025 | 25,412.00 |
| Mar 31, 2025 | 25,412.00 |
| Dec 31, 2024 | 447,142.00 |
| Dec 31, 2024 | 447,142.00 |
| Sep 30, 2024 | -281,495.00 |
| Sep 30, 2024 | -281,495.00 |
| Jun 30, 2024 | 139,923.00 |
| Jun 30, 2024 | 139,923.00 |
| Mar 31, 2024 | -31,351.00 |
| Mar 31, 2024 | -31,351.00 |
| Dec 31, 2023 | -184,459.00 |
| Dec 31, 2023 | -184,459.00 |